Archives: Speakers

Dr. Christiana Hofmann

From my educational background I am biologist. I have completed my PhD at the Helmholtz Research Centre of Munich in cooperation with the Technical University of Munich in the field of toxicology.

After that I gained several years of experience in the pharmaceutical industry with a focus on quality management.

Since nearly 4 years, I am working within TÜV SÜD in the sector of Medical Health Services. Currently, I am leading a team of experts and auditors for non-active medical devices and I am responsible for the Article 117 business in the regions DACH & Nordics.

Besides these roles, I am Auditor and Senior Product Specialist for non-active medical devices.

Dr Tobias Kruse

He is the founder and former CEO of Trials24, a company supporting biotech and pharmaceutical companies, as well as CROs, in accelerating patient recruitment. Trials24 was acquired by SubjectWell in September 2024 prior to its merger with Clariness.

Before founding Trials24, Tobias co-founded ImevaX, a biotech company focused on vaccine development, where he developed the entire digital patient recruitment strategy.

Tobias earned his PhD in Molecular Biotechnology from the Technical University of Munich, where he developed a vaccine against Helicobacter pylori. He holds numerous patents and has published papers in journals such as Nature and EMBO.